Takeda Pharmaceuticals is cutting more than 200 jobs across its U.S. workforce as it prepares for an upcoming loss of ...

Eastern North Carolina's biomanufacturing sector is experiencing unprecedented growth, with the region capturing the lion's ...

Indiana Gov. Mike Braun today highlighted the surge in Indiana’s life sciences sector, with three major industry expansions ...

Thermo Fisher Scientific's pharmaceutical services business has won a number of contracts to help its customers move ...

Drug products for oncology and neurological diseases will be manufactured in a second facility Johnson & Johnson plans to ...

Johnson & Johnson’s second facility in Wilson, North Carolina, is part of a $55 billion push to make all advanced medicines ...

Innovators and experts from Boehringer Ingelheim came to Quinnipiac to network with ambitious Bobcats and discuss impactful internship opportunities and diverse career pathways at one of the world's ...

Vertex's core business continues to drive strong financial results. The biotech has an exciting late-stage pipeline that could make significant progress in the next few years. It's a good idea to go ...

Shares of Zymeworks and Jazz Pharmaceuticals climbed after the companies released what they called positive topline results from a late-stage trial of their treatment for certain cancers, including of ...

We invite researchers to submit abstracts for oral presentations in the field of medicinal chemistry, focusing on the latest innovations in drug design, discovery, and development. Topics of… Read ...

Neurological biotech Acadia Pharmaceuticals recently rolled out a rebrand as it seeks to expand further into the rare disease space. As is the case with most life sciences companies these days, AI ...

WASHINGTON, DC: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla in the Oval Office of the White House as he announces a deal with Pfizer to lower drug prices on September 30, ...